9.1(top 2%)
impact factor
953(top 20%)
papers
32.1K(top 10%)
citations
91(top 5%)
h-index
9.2(top 2%)
impact factor
1.1K
all documents
37.6K
doc citations
144(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1Targeting TGF-β Signaling in CancerTrends in Cancer2017697
2Hypoxia-Inducible Factors: Master Regulators of Cancer ProgressionTrends in Cancer2016678
3Turning Cold into Hot: Firing up the Tumor MicroenvironmentTrends in Cancer2020562
4RNA-Binding Proteins in Cancer: Old Players and New ActorsTrends in Cancer2017528
5Glutamine Metabolism in Cancer: Understanding the HeterogeneityTrends in Cancer2017472
6Surviving at a Distance: Organ-Specific MetastasisTrends in Cancer2015419
7Endoplasmic Reticulum Stress and the Hallmarks of CancerTrends in Cancer2016406
8Circular RNAs in Cancer: Biogenesis, Function, and Clinical SignificanceTrends in Cancer2020401
9Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to BedsideTrends in Cancer2018389
10Glioblastoma: Defining Tumor NichesTrends in Cancer2015326
11The Role of Type 1 Conventional Dendritic Cells in Cancer ImmunityTrends in Cancer2018317
12Mitochondria, Bioenergetics and Apoptosis in CancerTrends in Cancer2017299
13Immunotherapy and Prevention of Pancreatic CancerTrends in Cancer2018296
14Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and TumorsTrends in Cancer2018286
15B Lymphocytes and Cancer: A Love–Hate RelationshipTrends in Cancer2016284
16Interplay between Circadian Clock and Cancer: New Frontiers for Cancer TreatmentTrends in Cancer2019274
17Metabolic Regulation of Macrophage Polarization in CancerTrends in Cancer2019273
18Radiotherapy: Changing the Game in ImmunotherapyTrends in Cancer2016270
19Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic OpportunitiesTrends in Cancer2019263
20Migrastatics—Anti-metastatic and Anti-invasion Drugs: Promises and ChallengesTrends in Cancer2017262
21Senescent Cells in Cancer Therapy: Friends or Foes?Trends in Cancer2020259
22KRAS Alleles: The Devil Is in the DetailTrends in Cancer2017257
23Breast Cancer: Multiple Subtypes within a Tumor?Trends in Cancer2017253
24Epigenetics and Cancer Stem Cells: Unleashing, Hijacking, and Restricting Cellular PlasticityTrends in Cancer2017252
25Targeting Transcription Factors in CancerTrends in Cancer2015247
26Re-Emergence of Dendritic Cell Vaccines for Cancer TreatmentTrends in Cancer2018247
27Migrating into the Tumor: a Roadmap for T CellsTrends in Cancer2017230
28Cancer Evolution and the Limits of Predictability in Precision Cancer MedicineTrends in Cancer2016222
29Long Noncoding RNAs in Cancer: From Function to TranslationTrends in Cancer2015218
30En Route to Metastasis: Circulating Tumor Cell Clusters and Epithelial-to-Mesenchymal TransitionTrends in Cancer2015218
31Super-Enhancer-Driven Transcriptional Dependencies in CancerTrends in Cancer2017217
32Glioblastoma Stem Cells: Driving Resilience through ChaosTrends in Cancer2020217
33CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic CancerTrends in Cancer2019214
34YAP/TAZ Signaling and Resistance to Cancer TherapyTrends in Cancer2019213
353D In Vitro Model (R)evolution: Unveiling Tumor–Stroma InteractionsTrends in Cancer2021209
36The Strange Case of CDK4/6 Inhibitors: Mechanisms, Resistance, and Combination StrategiesTrends in Cancer2017206
37The Genetic/Non-genetic Duality of Drug ‘Resistance’ in CancerTrends in Cancer2018201
38The Evolving Landscape of Brain MetastasisTrends in Cancer2018194
39The Immune Biology of Microsatellite-Unstable CancerTrends in Cancer2016193
40ALTernative Telomere Maintenance and CancerTrends in Cancer2015188
41Polytherapy and Targeted Cancer Drug ResistanceTrends in Cancer2019183
42Anti-CD73 in Cancer Immunotherapy: Awakening New OpportunitiesTrends in Cancer2016177
43Exosomes as a Multicomponent Biomarker Platform in CancerTrends in Cancer2020175
44Modeling Pancreatic Cancer with OrganoidsTrends in Cancer2016174
45Clinical Development of BRAF plus MEK Inhibitor CombinationsTrends in Cancer2020169
46Cancer Epigenetics, Tumor Immunity, and ImmunotherapyTrends in Cancer2020166
47Microfluidics: A New Tool for Modeling Cancer–Immune InteractionsTrends in Cancer2016163
48Resisting Resistance: Targeted Therapies in Lung CancerTrends in Cancer2016162
49The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic ViewTrends in Cancer2020162
50Gluconeogenesis in Cancer: Function and Regulation of PEPCK, FBPase, and G6PaseTrends in Cancer2019161